Research & Development



  只有從東邊的高地處挖掘,才有可能挖斷鉤子山的水脈。   郭解面帶笑容躬身施禮道︰“謝過司馬,標下已經從胥吏那里知曉了情由,既然大軍不能失期,標下這就去督促那些下三濫們即刻啟程。若是再有死傷,逃遁者,請司馬軍法處置!”免费一级特黄大片   想要穩定軍心,那麼,將軍們就必須時刻跟部下在一起,按照白日里的安排,霍去病去了刀盾兵,謝寧去了長槍兵,李敢去了騎兵,曹襄去了弩箭兵。日本一级特黄大片   “好,這就換!”   破舊代表了歷史,簇新代表了現在。超碰在线视频   裴炎皺眉道︰“這對其余駐軍不公!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo